KR940009047B1 - Method of manufacturing glutamine and iso-ascorbic acid-2-phosphate of ascorbic acid-2-phosphate - Google Patents

Method of manufacturing glutamine and iso-ascorbic acid-2-phosphate of ascorbic acid-2-phosphate Download PDF

Info

Publication number
KR940009047B1
KR940009047B1 KR1019910007993A KR910007993A KR940009047B1 KR 940009047 B1 KR940009047 B1 KR 940009047B1 KR 1019910007993 A KR1019910007993 A KR 1019910007993A KR 910007993 A KR910007993 A KR 910007993A KR 940009047 B1 KR940009047 B1 KR 940009047B1
Authority
KR
South Korea
Prior art keywords
phosphate
acid
ascorbic acid
glutamine
reaction
Prior art date
Application number
KR1019910007993A
Other languages
Korean (ko)
Other versions
KR920021714A (en
Inventor
신석봉
차두종
가와노 다까쭈구
Original Assignee
한국화약 주식회사
오재덕
생물과학산업연구소
다까쭈구가와노
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 한국화약 주식회사, 오재덕, 생물과학산업연구소, 다까쭈구가와노 filed Critical 한국화약 주식회사
Priority to KR1019910007993A priority Critical patent/KR940009047B1/en
Publication of KR920021714A publication Critical patent/KR920021714A/en
Application granted granted Critical
Publication of KR940009047B1 publication Critical patent/KR940009047B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00Preparation of nitrogen-containing organic compounds
    • C12P13/04Alpha- or beta- amino acids
    • C12P13/14Glutamic acid; Glutamine
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P9/00Preparation of organic compounds containing a metal or atom other than H, N, C, O, S or halogen

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

Iso ascorbic acid-2-phosphoric acid (I) or ascorbic acid-2-phosphoric acid (II) and L-glutamine (III) were synthesized without adenosine triphosphate. The microbes are corynebacterium glutamicum ATCC 13032 and microbacterium ammoniaphium ATCC 15354 etc..

Description

아스콜빈산-2-인산 또는 이소 아스콜빈산-2-인산과 글루타민의 제조방법Method for preparing ascorbic acid-2-phosphate or iso ascorbic acid-2-phosphate and glutamine

본 발명은 L-글루타민과 아스콜빈산-2-인산 또는 이소아스콜빈산-2-이산을 동일반응으로 제조하는 방법에 관한 것으로, 좀더 구체적으로는 L-글루타민산 생성능이 있는 코리네 박테리움속, 브레비박테리움속, 마이크로코커스속, 마이크로 박테리움속의 미생물 균체, 배양액 또는 이들의 처리물을 효소원으로 하고 아스콜빈산 화합물과 L-글루타민산을 기질로 하여 대응하는 인산화합물과 L-글루타민을 동시에 생성하는 방법에 관한 것이다.The present invention relates to a method for preparing L-glutamine and ascorbic acid 2-phosphate or isoascholic acid 2-diacid in the same reaction, more specifically, the genus Coryne bacterium having the ability to produce L- glutamic acid, Microbial cells of the genus Brevibacterium, Micrococcus, Microbacterium, cultures or their treated products are used as enzyme sources and ascorbic acid and L-glutamic acid as substrates. To generate.

L-글루타민은 위궤양, 십이지장궤양 등의 항궤양제 수액의 주요 성분으로서 대량으로 이용되고 있으며, 본 반응에 있어서 병행 생성되는 아스콜빈산-2-인산, 이소 아스콜빈산-2-인산은 비타민 C활성을 나타내는 안정한 화합물로서 의약, 식품 및 화장품 분야에 널리 이용되고 있다.L-glutamine is used in large quantities as a major component of anti-ulcer fluids such as gastric ulcer and duodenal ulcer. Ascorbic acid-2-phosphate and iso ascorbic acid-2-phosphate produced in this reaction are vitamin C As a stable compound exhibiting activity, it is widely used in medicine, food and cosmetics.

아스콜빈산과 관련한 인산화합물을 효소반응으로 제조하는 방법은 생체에너지 화합물인 아데노신 삼인산(ATP)가 관여하는 것으로서 아스콜빈산 또는 이소 아스콜빈산과 미생물, 효소를 작용시키는 방법들이 알려져 있다[일본국특허공개 평1-199590호 공보 및 일본농예화학회구문지. Agr. Biol, Chem, vol 54, No.12, P.3235-3239(1990)].A method for producing phosphate compounds related to ascorbic acid by enzymatic reaction involves adenosine triphosphate (ATP), which is a bioenergy compound, and known methods of reacting ascorbic acid or iso-ascorbic acid with microorganisms and enzymes. Japanese Unexamined Patent Publication No. 1-199590 and Japanese Agricultural Chemistry Association. Agr. Biol, Chem, vol 54, No. 12, P. 3235-3239 (1990)].

L글루타민의 제조방법으로는 글루타민 합성효소에 의해 에너지가 얻어지는 반응인 생화학적 방법(板食長六郞편 : 효모의 바이오사이언스(학회출판센터간행) : P.141-154(1990) 및 당질을 원료로 하는 세균에 의한 직접발효법(中西透 발효와 공업 40권 1호 p.15-20(1982))이 알려져 있다.The production method of L-glutamine is a biochemical method in which energy is obtained by glutamine synthetase (六 郞 食 長 바이오: Bioscience of yeast (published by Korean Society for Publication): P.141-154 (1990) and sugars. Direct fermentation by bacteria as a raw material (Middle-Western Fermentation and Industry 40 No. 1 p.15-20 (1982)) is known.

그러나, 아스콜빈산 또는 이소 아스콜빈산과 미생물 또는 효소를 작용시켜 아스콜빈산과 관련한 인산화합물의 선택적 인산화 반응을 진행시킴에 있어서 고가인 생체에너지 화합물인 아데노신삼인산 등의 공여체를 부원료로 반드시 이용하여야 하는 문제점이 있었으며, 글루타민과 아스콜빈산-2-인산 또는 이소아스콜빈산-2-인산을 혼합반응으로 생성하는 방법은 전혀 알려지지 않았었다.However, in the course of the selective phosphorylation reaction of ascorbic acid-related phosphate compounds by the action of ascorbic acid or iso ascorbic acid with microorganisms or enzymes, a donor such as adenosine triphosphate, an expensive bioenergy compound, must be used as an auxiliary material. There was no known method of producing a mixture of glutamine and ascorbic acid-2-phosphate or isoascholic acid-2-phosphate.

따라서, 본 발명의 목적은 생체에너지 화합물을 사용하지 않고 아스콜빈산-2-인산 또는 이소 아스콜빈산-2-인산을 제조하는 방법을 제공하는데 있다.Accordingly, an object of the present invention is to provide a method for producing ascorbic acid-2-phosphate or iso ascorbic acid-2-phosphate without using a bioenergy compound.

본 발명의 또다른 목적은 글루타민과 아스콜빈산-2-인산 또는 이소 아스콜빈산-2-인산을 혼합반응으로 동시에 제조하는 방법을 제공하는데 있다.It is another object of the present invention to provide a method for simultaneously preparing glutamine and ascorbic acid-2-phosphate or iso ascorbic acid-2-phosphate by a mixed reaction.

상술한 목적들을 달성하기 위해서 본 발명에서는 L-글루타민산 생성능이 있는 코리네박테리움속, 브레비박테리움속, 마이크로코커스속, 마이크로박테리움속의 미생물 균체, 배양액 또는 이들의 처리물을 효소원으로 하고 L-글루타민산과 아스콜빈산 또는 이소 아스콜빈산을 기질로 하여 아데노산 또는 아데닐산(5′-AMP), 완충액 성분을 첨가하여 반응시키고 이온교환수지를 사용하여 아스콜빈산-2-인산 또는 이소 아스콜빈산-2-인산과 L-글루타민 분리획득함으로써 생체에너지 화합물을 사용하지 않고 아스콜빈산-2-인산 또는 이소아스콜빈산-2-인산과 L-글루타민을 혼합반응으로 제조할 수 있었다.In order to achieve the above objects, in the present invention, L-glutamic acid-producing ability of the genus Corynebacterium, Brevibacterium, Micrococcus, Microbacterium microorganisms, cultures or their treatments as enzyme source L-glutamic acid and ascorbic acid or iso-ascorbic acid are used as a substrate to react with adeno acid or adenylic acid (5'-AMP) and a buffer component. Ascorbic acid-2-phosphate and L-glutamine were separately obtained, and thus, ascorbic acid 2-phosphate or isoascholic acid-2-phosphate and L-glutamine could be prepared by a reaction without using a bioenergy compound.

본 발명을 좀 더 구체적으로 설명하면 다음과 같다.The present invention is described in more detail as follows.

미생물을 유기화합물에 작용시켜 보다 더 유용한 유도체를 얻고자 하는 시험에서 미생물의 선택이 중요하다. 따라서, 본 발명에서는 L-글루타민산 생산균으로 알려진 코리네박테리움속, 브레비박테리움속, 마이크로코커스속, 마이크로 박테리움속으로 분류된 균주중에서 아스콜빈산 화합물(아스콜빈산, 이소아스콜빈산)과 L-글루타민산을 기질로 하여 대응하는 인산화합물과 L-글루타민을 동시에 생성하는 균주를 선별하였다.The choice of microorganisms is important in tests in which microorganisms can act on organic compounds to yield more useful derivatives. Therefore, in the present invention, ascorbic acid compounds (ascorbic acid, isoascolvinic acid) among strains classified into the genus Corynebacterium, Brevibacterium, Micrococcus, and Microbacterium known as L-glutamic acid producing bacteria. ) And L-glutamic acid as substrates were selected strains that simultaneously produce the corresponding phosphate compound and L-glutamine.

선별된 균주는 현재 일반분양이 가능하므로 상업적으로 구입할 수 있지만 변이처리로 얻어진 균주 및 자연계로부터 분리된 것도 이용할 수 있다.Selected strains are currently available for general sale and can be purchased commercially, but strains obtained by mutating and isolated from nature can also be used.

그다음에 선별된 균주를 일반적인 세균배양법 등에 통상적으로 사용되는 배지 예를들어, 전분, 포도당, 슈크로즈, 페당밀 등의 탄소원과 펩톤, 육엑시스, 효모 엑기스, C,S,L 요소, 암모니움염 등의 질소원 및 기타 미생물의 생육에 필요한 인산염, 황산마그네슘, 기타 미량금속 등으로 이루어진 배지에 증식시킨다. 특히, L-글루타민산의 발효를 목적으로 개발된 배지, 예를 들어 일본특허공고 소45-110호 공보에 기재된 배지를 사용하여 배양할때 균체내의 효소활성이 높은 균주를 본 발명에 사용하는 것이 바람직하다.The selected strains are then used as a medium commonly used in general bacterial culture methods, for example, carbon sources such as starch, glucose, sucrose, and sucrose, peptone, hexaaxis, yeast extract, C, S, L urea, ammonium salt, etc. It is grown in a medium consisting of phosphate, magnesium sulfate, and other trace metals necessary for the growth of nitrogen sources and other microorganisms. In particular, when cultured using a medium developed for the fermentation of L-glutamic acid, for example, a medium described in Japanese Patent Publication No. 45-110, it is preferable to use a strain having high enzymatic activity in cells in the present invention. Do.

배양된 균체는 그 자체가 효소로서 본 발명의 반응을 진행시키지만, 균체를 아세톤, 에탄올, 에테르 등의 용매로 처리하여 분말화한 세정균체의 동결건조물 등의 형태 또는 부분정제한 효소단백 또는 고정화 효소로도 충분한 활성을 나타내기 때문에 고정화균체를 포함하여 소위 바이오리액터에 의한 반응 생성공정으로 아스콜빈산-2-인산 또는 이소아스콜빈산-2-인산과 L-글루타민을 함께 제조할 수 있다.The cultured cells themselves proceed with the reaction of the present invention as an enzyme, but in the form or partially purified enzyme protein or immobilized enzyme of a lyophilized product of the washed cells, which is powdered by treating the cells with a solvent such as acetone, ethanol or ether. Since it exhibits sufficient activity, ascorbic acid-2-phosphate or isoascholic acid-2-phosphate and L-glutamine can be produced together by a reaction generating process by a so-called bioreactor including immobilized cells.

그다음에 L-글루타민산, 아스콜빈산 관련화합물을 기질로하고 아데노산 또는 아데닐산(5′-AMP), 완충액성분, 계면활성제, 무수인산염, 금속염 등을 첨가한 후, 상술한 미생물 균체, 배양액 또는 이들의 처리물을 효소원으로 하여 반응시킴으로서 L-글루타민과 아스콜빈산 또는 이소 아스콜빈산을 동시에 생성시켰다.Subsequently, L-glutamic acid and ascorbic acid related compounds are used as a substrate, and adeno acid or adenylic acid (5′-AMP), a buffer component, a surfactant, an anhydrous phosphate, a metal salt, and the like are added. By reacting these treatments with the enzyme source, L-glutamine and ascorbic acid or iso ascorbic acid were simultaneously produced.

특히, 반응액에 계면활성제를 가해 반응진행을 원활히 하는 것이 효과적이다.In particular, it is effective to add a surfactant to the reaction solution to facilitate the reaction progress.

이경우 폴리옥시에틸렌솔비탄, 모노스테아레이트 등의 비이온성 계면활성제 및 폴리옥시에틸렌스테아릴아민, 세틸트리메틸암모니움브로마이드 등의 양이온 계면활성제 및 나트륨 올레일 아마이드황산 등의 음이온 계면활성제군 중에서 사용균주의 특성에 따라 적절히 선택하여 1∼50㎎/㎖의 농도로 반응액에 첨가하는 것이 바람직하다.In this case, nonionic surfactants such as polyoxyethylene sorbitan and monostearate and cationic surfactants such as polyoxyethylene stearylamine and cetyltrimethylammonium bromide and anionic surfactant groups such as sodium oleamide sulphate It is preferable to add it to a reaction liquid at the density | concentration of 1-50 mg / ml, selecting suitably according to a characteristic.

본 발명에 있어서, 아데노신 또는 5′AMP는 상기의 미생물에 의해 ATP로 변환되어 L-글루타민, 아스콜빈산 관련 인산 화합물의 생성에 보조적인 역할을 하는 작용을 하며, 인산마그네슘, 인산칼륨과 같은 무기인산염이 사용되고, 금속염으로서 망간, 마그네슘염이나 철, 아연, 동 등이 미량 첨가된다.In the present invention, adenosine or 5'AMP is converted to ATP by the microorganisms, and plays an auxiliary role in the production of L-glutamine, ascorbic acid-related phosphate compounds, and minerals such as magnesium phosphate and potassium phosphate. Phosphate is used, and a trace amount of manganese, magnesium salt, iron, zinc, copper, etc. is added as a metal salt.

반응의 조건은 효소가 실활되지 않는 범위이면 특별한 제한이 없지만, 통상 pH 4.5∼9.0, 반응온도 5∼40℃가 양호하였다.The conditions of the reaction are not particularly limited as long as it is a range in which the enzyme is inactivated, but pH 4.5 to 9.0 and a reaction temperature of 5 to 40 ° C are generally good.

반응은 정치 또는 교반조건하에서 행하지만 효소의 분산을 좋게하면 반응은 단시간에 진행되었다. 금속염으로서 반응의 진행중에 마그네슘, 망간염을 첨가하면 ATP생성을 원활하게 촉진시켰다.The reaction was carried out under stationary or stirring conditions, but the reaction proceeded in a short time when the dispersion of the enzyme was improved. The addition of magnesium and manganese salts during the course of the reaction as metal salts facilitated ATP production.

본 반응계에서 L-글루타민산을 기질로 첨가하지 않는 경우에는 아스콜빈산의 인산화가 전혀 이루어지지 않는 것으로부터 알수 있듯이 L-글루타민 합성 반응시의 반응인 5′-AMP→→ATP의 에너지 공급반응이 이소 아스콜빈산-2-인산생성을 수반하였다.In the case where L-glutamic acid is not added as a substrate in this reaction system, asosbinic acid is not phosphorylated at all, the energy supply reaction of 5′-AMP →→ ATP, which is a reaction during the synthesis of L-glutamine, isoisolate. Ascorbic acid-2-phosphate production was involved.

즉, 반응액에서 아스콜빈산을 제거하여 L-글루타민산만을 기질로 하는 반응에서 반응액 중에 1.5g/dl의 고농도의 ATP가 글루타민과 함께 생성되는 것으로부터도 실제 확인할 수 있었다.In other words, it was also confirmed that high concentration of ATP of 1.5 g / dl was generated together with glutamine in the reaction solution by removing ascorbic acid from the reaction solution and using only L-glutamic acid as a substrate.

이 ATP가 아스콜빈산에 대해 인산공여체로서 사용되며 또한 반응계내에서 ATP의 재생이 이루어지는 것으로 추정된다.It is assumed that this ATP is used as a phosphate donor for ascorbic acid and that ATP regeneration occurs in the reaction system.

반응시의 기질농도는 아스콜빈산, 이소아스콜빈산 및 L-글루타민등 어느 것이든 0.5 또는 5g/dl, 그리고 아데노신 또는 5′-AMP의 사용농도는 500㎎-1.5g/dl 정도가 양호하였으며 반응은 10시간 이내로 종료되었다.Substrate concentrations in the reaction were 0.5 or 5 g / dl in any of ascorbic acid, isoascholic acid and L-glutamine, and adenosine or 5′-AMP was in the range of 500 mg-1.5 g / dl. The reaction was completed within 10 hours.

반응종료액에서 이온교환수지에 의해 (이소)아스콜빈산-2-인산의 산성, L-글루타민의 염기성을 이용하여 분취함으로서 생성물을 회수하였다.The product was recovered from the reaction mixture by using an ion exchange resin for fractionation using the acidity of (iso) ascorbic acid-2-phosphate and the basicity of L-glutamine.

다음의 실시예에는 본 발명에 의한 생성물들의 제조방법 및 효과를 좀더 구체적으로 설명하는 것이지만, 본 발명의 범주를 한정하는 것은 아니다.The following examples further illustrate the production methods and effects of the products according to the invention, but are not intended to limit the scope of the invention.

하기 실시예에 있어서 글루타민의 측정은 글루타민아제에 의한 효소분해와 글루타민산 탈탄산효소를 조합시킨 방법으로 행하였으며, 아스콜빈산-2-인산, 이소 아스콜빈산-2-인산은 A, 村山들에 의한 고속액체 크로마토그라피(HPLC)법에 준하였다. [Agr. Biol. Chem, 54권, 9호, p.2310(1990) 참조]In the following examples, the determination of glutamine was performed by a combination of glutamine dehydrogenase and glutamate decarboxylase, and ascorbic acid-2-phosphate and iso ascorbic acid-2-phosphate were measured in A, yamasan. By high performance liquid chromatography (HPLC) method. Agr. Biol. Chem, 54, 9, p. 2310 (1990)]

[실시예 1]Example 1

[L-글루타민 생성효소의 조제][Preparation of L-glutamine synthase]

글루타민산 생산균주의 일종인 코리네박테리움 메라세코라(Corynebacterinm melassecola) ATCC 17965(일본특허공고 소45-110호 공보참조)를 하기의 조성으로 이루어진 배지에서 통기교반 배양하여 균체를 얻었다.Corynebacterium melassecola ATCC 17965 (see Japanese Patent Publication No. 45-110), a kind of glutamic acid producing strain, was cultured through aeration in a medium having the following composition to obtain cells.

사탕무우 폐당밀 7.0g/dlBeet Sorghum 7.0g / dl

요 소 1.5g/dlElement 1.5g / dl

KH2PO40.2g/dlKH 2 PO 4 0.2g / dl

(NH4)2SO40.1g/dl(NH 4 ) 2 SO 4 0.1g / dl

MgSO4·7H2O 50mgMgSO 4 7H 2 O 50mg

논이온 S-6(비이온 계면활성제 : 일본지사 상품) 130mgNon-ion S-6 (Non-ionic Surfactant: 130 Japan)

pH 7.2pH 7.2

얻어진 균체는 원심분리하여 세정균체로서 통상의 방법으로 알긴산겔내에서 포괄고정화 균체로 하여 L-글루타민 생성효소로 하였다.The obtained cells were centrifuged to form L-glutamine synthase as the encapsulated and immobilized cells in the alginate gel by a conventional method as washing cells.

(효소반응)(Enzyme reaction)

L-글루타민산나트륨 5.0g5.0 g of sodium L-glutamate

아데노신 2.5gAdenosine 2.5g

인산제일칼륨 9.0gPotassium Phosphate 9.0g

인산제이나트륨 14.1gDisodium Phosphate 14.1g

포도당 15.0gGlucose 15.0 g

황산암모니움 15.0gAmmonium sulfate 15.0 g

나이민 S-215(계면활성제 : 일반유지사 상품) 1.5gNiamine S-215 (Surfactant: general oils and fats) 1.5g

물 500ml500 ml of water

상기 조성으로 이루어진 반응액을 pH 6.5로 조정하고 균체 10g을 포괄시킨 고정화 균체효소를 부유시켜 교반조건 15rpm으로 37℃에서 1.5시간 반응시킨 후, 여기에 아스콜빈산 나트륨 5.0g을 첨가하여 3.5시간 반응을 지속하였다.After adjusting the reaction solution having the composition to pH 6.5 and floating the immobilized mycelium enzyme encapsulated with 10 g of the cells and reacting for 15 hours at 37 ° C. at 15 rpm, the reaction solution was added 3.5 g of sodium ascorbate to the reaction for 3.5 hours. Continued.

반응액중의 생성물을 정량한 결과, L-글루타민은 4.6g/dl, 아스콜빈산-2-인산은 3.8g/dl이었다.As a result of quantification of the product in the reaction solution, L-glutamine was 4.6 g / dl, and ascorbic acid-2-phosphate was 3.8 g / dl.

이 반응액을 과열처리하고 침전물을 원심분리하여 제거한후, pH4.5로 조정한 반응액을 앰버라이트 1RA-900(cl형)에 흡착시켜 아스콜빈산-2-인산을 분리하였고, 통과액을 다우웩스 50(H형)에 통과시켜 L-글루타민을 흡착시키고 각각의 분획성분을 통상의 방법으로 처리하여 결정화 하였다. 일차결정으로서 L-글루타민 3.8g, 아스콜빈산-2-인산칼슘 3.4g을 회수하였다.The reaction solution was superheated and the precipitate was removed by centrifugation, and then the reaction solution adjusted to pH 4.5 was adsorbed onto Amberlite 1RA-900 (cl type) to separate ascorbic acid-2-phosphate. L-glutamine was adsorbed through Dow's 50 (H type) and each fraction was crystallized by a conventional method. As primary crystals, 3.8 g of L-glutamine and 3.4 g of ascorbic acid-2-calcium phosphate were recovered.

[실시예 2]Example 2

효소원 미생물로서 브레비박테리움 락토퍼멘탐(Brevibacterium lactofermen tam) ATCC 13655 균주의 페니실린 내성 변이주 RIIBS-1039주를 사용하고 반응시 아스콜빈산 대신에 이소 아스콜빈산 나트륨을, 계면활성제로서 세틸피리미디움크로라이드 1.0g을 이용한 것을 제외하고는 실시예 1과 동일하게 반응을 진행시켰다.As enzyme source microorganisms, penicillin resistant mutant RIIBS-1039 strain of Brevibacterium lactofermen tam ATCC 13655 strain was used, and sodium isocholate acid instead of ascorbic acid was reacted with cetylpyrididium as a surfactant. The reaction was carried out in the same manner as in Example 1 except that 1.0 g of chromide was used.

얻어진 반응액 중에는 L-글루타민이 4.1g/dl, 이소아스콜빈산-2-인산이 3.2g/dl 생성된 것을 확인하였다.It was confirmed that 4.1 g / dl of L-glutamine and 3.2 g / dl of isoascholic acid 2-phosphate were produced in the obtained reaction liquid.

[실시예 3]Example 3

코리네박테리움 그루타미캄(Corynebacterium glutamicum) ATCC 13032 균주를 실시예 1과 동일한 방법으로 배양한 후, 균체를 세정하고 고정화시키지 않고 동결건조 균체를 얻고, 이 균체 5g을 반응액에 첨가한 것을 제외하고는 실시예 1과 동일한 방법으로 효소반응시킨 결과, 반응종료액에서 L-글루타민 4.0g/dl, 아스콜빈산-2-인산 2.8g을 얻었다.After culturing Corynebacterium glutamicum ATCC 13032 strain in the same manner as in Example 1, lyophilized cells were obtained without washing and immobilizing the cells, except that 5 g of the cells were added to the reaction solution. As a result of the enzymatic reaction in the same manner as in Example 1, 4.0 g / dl of L-glutamine and 2.8 g of ascorbic acid-2-phosphate were obtained from the reaction solution.

[실시예 4]Example 4

미크로박테리움 암모니아피람(Microbacterium ammoniaphium) ATCC 15354균주를 실시예 1과 동일한 방법으로 배양한 후, 냉각된 아세톤으로 처리한 건조균체를 효소원으로 하고 반응액에 아데노산 대신 Na-5′-AMR를 이용한 것을 제외하고는 실시예 1과 동일한 방법으로 효소반응시킨 결과, 반응종료액에서 L-글루타민 3.9g/dl, 아스콜빈산-2-인산 3.5g을 얻었다.After incubating the microbacterium ammoniaphium ATCC 15354 strain in the same manner as in Example 1, the dried cells treated with cooled acetone were the enzyme source, and Na-5′-AMR was used instead of adeno acid in the reaction solution. As a result of the enzymatic reaction in the same manner as in Example 1 except for the use, L-glutamine 3.9 g / dl and 3.5 g ascorbic acid-2-phosphate were obtained from the reaction solution.

[비교예 1]Comparative Example 1

효소반응 조성물에 L-글루타민산 나트륨을 첨가하지 않은 것을 제외하고는 실시예 1과 동일한 방법으로 효소반응시킨 결과, 아스콜빈산의 인산화 생성물이 생성되지 않았다.As a result of the enzymatic reaction in the same manner as in Example 1, except that sodium L-glutamate was not added to the enzyme reaction composition, phosphorylation products of ascorbic acid were not produced.

[비교예 2]Comparative Example 2

아스콜빈산을 추가로 첨가하지 않은 것을 제외하고는 실시예 1과 동일한 방법으로 반응을 진행시킨 결과, 반응액중에 2.3g/dl 농도의 ATP가 생성되었다.The reaction was carried out in the same manner as in Example 1 except that no additional ascorbic acid was added. As a result, ATP having a concentration of 2.3 g / dl was generated in the reaction solution.

상술한 바와 같이, 기질로서 L-글루타민산과 아스콜빈산 또는 이소아스콜빈산을 함유하는 반응액에 L-글루타민산으로부터 L-글루타민을 생성하는 능력을 지닌 세균군에서 선발한 균체 또는 효소를 반응시키고 반응액을 이온교환수지를 사용하여 분취함으로서 아스콜빈산-2-인산 또는 이소아스콜빈산-2-인산과 글루타민을 동시에 용이하게 제조할 수 있었다.As described above, the reaction solution containing L-glutamic acid and ascorbic acid or isoascholic acid as a substrate reacts and reacts cells or enzymes selected from a bacterial group having the ability to produce L-glutamine from L-glutamic acid. By separating the liquid using an ion exchange resin, ascorbic acid-2-phosphate or isoascholic acid-2-phosphate and glutamine were easily produced at the same time.

Claims (9)

기질로서 L-글루타민산과 아스콜빈산 또는 이소 아스콜빈산을 함유하는 반응액에 L-글루타민산으로부터 L-글루타민을 생성하는 능력을 지닌 코리네박테리움 메라세라 ATCC 17965, 브레비박테리움 락토퍼멘탐 ATCC 13655의 페니실린 내성 변이주 RIIBS-1039, 코리네박테리움 그리타미캄 ATCC 13032 또는 미크로박테리움 암모니아피람 ATCC 15354를 작용시키는 것을 특징으로 하는 아스콜빈산-2-인산 또는 이소 아스콜빈산-2-인산과 글루타민의 제조방법.Corynebacterium merracera ATCC 17965, Brevibacterium lactofermentam ATCC, having the ability to produce L-glutamine from L-glutamic acid in a reaction solution containing L-glutamic acid and ascolic acid or iso ascolic acid as a substrate 13655 penicillin resistant mutant RIIBS-1039, Corynebacterium gritamicam ATCC 13032 or Microbacterium ammoniapyram ATCC 15354, with ascorbic acid-2-phosphate or iso ascorbic acid-2-phosphate Method for preparing glutamine. 제1항에 있어서, 반응액은 계면활성제, 아데노산 또는 아데닐산, 무기인산염, 금속염, 완충액 성분을 함유하는 것을 특징으로 하는 방법.The method of claim 1, wherein the reaction solution contains a surfactant, adeno acid or adenylic acid, an inorganic phosphate, a metal salt, and a buffer component. 제2항에 있어서, 계면활성제는 폴리옥시에틸렌솔비탄, 모노스테아레이트 폴리옥시에틸렌스테아릴아민, 세틸트리메틸 암모니움 브로마이드, 나트륨올레일아마이드황산으로 구성된 군으로부터 선택된 것을 1∼50㎎/㎖의 농도로 첨가함을 특징으로 하는 방법.According to claim 2, wherein the surfactant is selected from the group consisting of polyoxyethylene sorbitan, monostearate polyoxyethylene stearylamine, cetyltrimethyl ammonium bromide, sodium oleamide sulphate concentration of 1 to 50 mg / ㎖ Characterized in that the addition. 제2항에 있어서, 무기인산염은 인산 마그네슘, 인산칼륨임을 특징으로 하는 방법.The method of claim 2 wherein the inorganic phosphate is magnesium phosphate, potassium phosphate. 제2항에 있어서, 금속염은 망간, 마그네슘, 철, 아연, 동염임을 특징으로 하는 방법.The method of claim 2, wherein the metal salt is manganese, magnesium, iron, zinc, copper salt. 제1항에 있어서, 균체는 고정화 균체임을 특징으로 하는 방법.The method of claim 1, wherein the cells are immobilized cells. 제1항에 있어서, 효소반응은 pH 4.5∼90, 반응온도는 5∼40℃로 행함을 특징으로 하는 방법.The method according to claim 1, wherein the enzymatic reaction is performed at a pH of 4.5 to 90 and a reaction temperature of 5 to 40 ° C. 제2항에 있어서, 아데노신 또는 아데닐산은 50㎎∼1.5g/dl의 농도로 첨가됨을 특징으로 하는 방법.The method of claim 2, wherein adenosine or adenylic acid is added at a concentration of 50 mg to 1.5 g / dl. 제1항에 있어서, 생성물의 분리는 이온교환수지를 이용하여 분취함을 특징으로 하는 방법.The method of claim 1, wherein the separation of the product is characterized in that the separation using an ion exchange resin.
KR1019910007993A 1991-05-16 1991-05-16 Method of manufacturing glutamine and iso-ascorbic acid-2-phosphate of ascorbic acid-2-phosphate KR940009047B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019910007993A KR940009047B1 (en) 1991-05-16 1991-05-16 Method of manufacturing glutamine and iso-ascorbic acid-2-phosphate of ascorbic acid-2-phosphate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019910007993A KR940009047B1 (en) 1991-05-16 1991-05-16 Method of manufacturing glutamine and iso-ascorbic acid-2-phosphate of ascorbic acid-2-phosphate

Publications (2)

Publication Number Publication Date
KR920021714A KR920021714A (en) 1992-12-18
KR940009047B1 true KR940009047B1 (en) 1994-09-29

Family

ID=19314558

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019910007993A KR940009047B1 (en) 1991-05-16 1991-05-16 Method of manufacturing glutamine and iso-ascorbic acid-2-phosphate of ascorbic acid-2-phosphate

Country Status (1)

Country Link
KR (1) KR940009047B1 (en)

Also Published As

Publication number Publication date
KR920021714A (en) 1992-12-18

Similar Documents

Publication Publication Date Title
SU1731067A3 (en) Method of l-2-amino-4-(hydroxymethylphosphinyl)-butyric acid preparation
US2749279A (en) Enzymatic production of l-glutamic acid
EP0096547B1 (en) Process for preparing uridine diphosphate-n-acetylgalactosamine
EP0282989A2 (en) Process for producing 5'-inosinic acid
KR940009047B1 (en) Method of manufacturing glutamine and iso-ascorbic acid-2-phosphate of ascorbic acid-2-phosphate
EP0319130B1 (en) Process for the preparation of ascorbic acid-2-phosphate
US5212079A (en) Process for the preparation of ascorbic acid-2-phosphate
JPS6174595A (en) Production of substance
EP0272064B1 (en) A process for the preparation of ascorbic acid-2-phosphate
EP0146265B1 (en) Process for producing a compound from its precursor using an enzymatic activity of bacterium
US3787288A (en) Method for preparing alpha-aminobenzylpenicillin
JP2602927B2 (en) Method for producing adenosine-5'-triphosphate
JPS63279798A (en) Production of s-adenosylmethionine
TACHIKI et al. Glutamine production in high concentrations with energy transfer employing glutamine synthetase from Micrococcus glutamicus
JPH0328195B2 (en)
JPS60105499A (en) Production of glutathione
JPS6174596A (en) Production of gamma-glutamylcysteine
JPH0254077B2 (en)
JPS5818075B2 (en) Method for producing adeno-5'-triphosphoric acid
EP0323068A2 (en) Enzymatic carbon-carbon bond formation
JPS58877B2 (en) l↓-Production method of coronaminic acid
JPH05328985A (en) Production of ascorbic acid-2-phosphoric acid, iso-ascorbic acid-2-phosphoric acid and glutamine
KR830002328B1 (en) Method for preparing L-Tryptophan by enzyme
JPS58146286A (en) Preparation of selenium-containing amino acid
EP0289796B1 (en) Method of treating microorganism cells containing tryptophanase or treated product thereof

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 19970829

Year of fee payment: 4

LAPS Lapse due to unpaid annual fee